Passage BIO's three largest insider shareholders as of August 04, 2026 are Capital Management Lp Lynx1 (TenPercentOwner, 9.26Mn shares), Advisors Llc Orbimed (TenPercentOwner, 6.84Mn shares), Advisors Llc Orbimed (TenPercentOwner, 6.07Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Advisors Llc Orbimed | - | 0 | 6,841,423 | 05 May, 2022 |
| Bruce A Goldsmith | Ceo And President | 15,983 | 0 | 23 Mar, 2022 |
| Jill M. Quigley | Chief Operating Officer | 368,754 | 0 | 10 Dec, 2021 |
| Edgar B. Cale | Gc Corporate Secretary | 45,995 | 0 | 03 Jan, 2024 |
| Alexandros Fotopoulos | Chief Technical Officer | 28,693 | 0 | 20 Jun, 2023 |
| Monika Maria Toernsen | Chief Commercial Officer | 3,319 | 0 | 18 Nov, 2022 |
| Simona King | Chief Financial Officer | 23,994 | 0 | 01 Aug, 2023 |
| Capital Management Lp Lynx1 | - | 0 | 9,256,953 | 31 Dec, 2024 |
| Mark S Forman | Chief Medical Officer | 45,269 | 0 | 03 Jan, 2024 |
| William Chou | President And Ceo | 6,524 | 0 | 12 Jan, 2026 |
| Kathleen Borthwick | Cfo | 5,402 | 0 | 12 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Mar, 2026 | William Chou | Employee Stock Option (right to buy) | A | 58,000 | $0.00 | 58,000 | D | A |
| 16 Mar, 2026 | Kathleen Borthwick | Employee Stock Option (right to buy) | A | 15,610 | $0.00 | 15,610 | D | A |
| 08 Jan, 2026 | William Chou | Common Stock | A | 10,000 | - | 10,600 | D | M |
| 08 Jan, 2026 | Kathleen Borthwick | Common Stock | A | 5,000 | - | 7,464 | D | M |
| 08 Jan, 2026 | William Chou | Common Stock | D | 4,076 | $18.44 | 6,524 | D | S |
| 08 Jan, 2026 | Kathleen Borthwick | Common Stock | D | 2,062 | $18.44 | 5,402 | D | S |
| 08 Jan, 2026 | Kathleen Borthwick | Restricted Stock Unit | D | 5,000 | $0.00 | 5,000 | D | M |
| 08 Jan, 2026 | William Chou | Restricted Stock Unit | D | 10,000 | $0.00 | 10,000 | D | M |
| 11 Sep, 2025 | Capital Management Lp Lynx1 | Common stock, $0.0001 par value per share (Common Stock) | A | 325 | $6.96 | 592,021 | I | P |
| 12 Sep, 2025 | Capital Management Lp Lynx1 | Common Stock | A | 19,783 | $6.99 | 611,804 | I | P |
| 15 Sep, 2025 | Capital Management Lp Lynx1 | Common Stock | A | 11,900 | $6.99 | 623,704 | I | P |
| 22 Jul, 2025 | Capital Management Lp Lynx1 | Common stock, $0.0001 par value per share (Common Stock) | A | 13,123 | $5.44 | 475,971 | I | P |
| 23 Jul, 2025 | Capital Management Lp Lynx1 | Common Stock | A | 49,302 | $5.74 | 525,273 | I | P |
| 24 Jul, 2025 | Capital Management Lp Lynx1 | Common Stock | A | 66,423 | $5.71 | 591,696 | I | P |
| 24 Jun, 2025 | Advisors Llc Orbimed | Common Stock | D | 231,600 | $0.35 | 6,418,400 | I | S |
| 25 Jun, 2025 | Advisors Llc Orbimed | Common Stock | D | 138,800 | $0.33 | 6,279,600 | I | S |
| 26 Jun, 2025 | Advisors Llc Orbimed | Common Stock | D | 213,257 | $0.33 | 6,066,343 | I | S |
| 28 May, 2025 | Derrell Porter | Director Stock Option (right to buy) | A | 201,857 | $0.00 | 201,857 | D | A |
| 28 May, 2025 | Derrell Porter | Director Stock Option (right to buy) | A | 201,857 | $0.00 | 201,857 | D | A |
| 28 May, 2025 | Dolan Sondhi | Director Stock Option (right to buy) | A | 201,857 | $0.00 | 201,857 | D | A |